Back
About RSIS
Introduction
Building the Foundations
Welcome Message
Board of Governors
Staff Profiles
Executive Deputy Chairman’s Office
Dean’s Office
Management
Distinguished Fellows
Faculty and Research
Associate Research Fellows, Senior Analysts and Research Analysts
Visiting Fellows
Adjunct Fellows
Administrative Staff
Honours and Awards for RSIS Staff and Students
RSIS Endowment Fund
Endowed Professorships
Career Opportunities
Getting to RSIS
Research
Research Centres
Centre for Multilateralism Studies (CMS)
Centre for Non-Traditional Security Studies (NTS Centre)
Centre of Excellence for National Security (CENS)
Institute of Defence and Strategic Studies (IDSS)
International Centre for Political Violence and Terrorism Research (ICPVTR)
Research Programmes
National Security Studies Programme (NSSP)
Social Cohesion Research Programme (SCRP)
Studies in Inter-Religious Relations in Plural Societies (SRP) Programme
Other Research
Future Issues and Technology Cluster
Research@RSIS
Science and Technology Studies Programme (STSP) (2017-2020)
Graduate Education
Graduate Programmes Office
Exchange Partners and Programmes
How to Apply
Financial Assistance
Meet the Admissions Team: Information Sessions and other events
RSIS Alumni
Outreach
Global Networks
About Global Networks
RSIS Alumni
Executive Education
About Executive Education
SRP Executive Programme
Terrorism Analyst Training Course (TATC)
International Programmes
About International Programmes
Asia-Pacific Programme for Senior Military Officers (APPSMO)
Asia-Pacific Programme for Senior National Security Officers (APPSNO)
International Conference on Cohesive Societies (ICCS)
International Strategy Forum-Asia (ISF-Asia)
Publications
RSIS Publications
Annual Reviews
Books
Bulletins and Newsletters
RSIS Commentary Series
Counter Terrorist Trends and Analyses
Commemorative / Event Reports
Future Issues
IDSS Papers
Interreligious Relations
Monographs
NTS Insight
Policy Reports
Working Papers
External Publications
Authored Books
Journal Articles
Edited Books
Chapters in Edited Books
Policy Reports
Working Papers
Op-Eds
Glossary of Abbreviations
Policy-relevant Articles Given RSIS Award
RSIS Publications for the Year
External Publications for the Year
Media
News Releases
Speeches
Video/Audio Channel
Events
Contact Us
S. Rajaratnam School of International Studies Think Tank and Graduate School Ponder The Improbable Since 1966
Nanyang Technological University Nanyang Technological University
  • About RSIS
      IntroductionBuilding the FoundationsWelcome MessageBoard of GovernorsHonours and Awards for RSIS Staff and StudentsRSIS Endowment FundEndowed ProfessorshipsCareer OpportunitiesGetting to RSIS
      Staff ProfilesExecutive Deputy Chairman’s OfficeDean’s OfficeManagementDistinguished FellowsFaculty and ResearchAssociate Research Fellows, Senior Analysts and Research AnalystsVisiting FellowsAdjunct FellowsAdministrative Staff
  • Research
      Research CentresCentre for Multilateralism Studies (CMS)Centre for Non-Traditional Security Studies (NTS Centre)Centre of Excellence for National Security (CENS)Institute of Defence and Strategic Studies (IDSS)International Centre for Political Violence and Terrorism Research (ICPVTR)
      Research ProgrammesNational Security Studies Programme (NSSP)Social Cohesion Research Programme (SCRP)Studies in Inter-Religious Relations in Plural Societies (SRP) Programme
      Other ResearchFuture Issues and Technology ClusterResearch@RSISScience and Technology Studies Programme (STSP) (2017-2020)
  • Graduate Education
      Graduate Programmes OfficeExchange Partners and ProgrammesHow to ApplyFinancial AssistanceMeet the Admissions Team: Information Sessions and other eventsRSIS Alumni
  • Outreach
      Global NetworksAbout Global NetworksRSIS Alumni
      Executive EducationAbout Executive EducationSRP Executive ProgrammeTerrorism Analyst Training Course (TATC)
      International ProgrammesAbout International ProgrammesAsia-Pacific Programme for Senior Military Officers (APPSMO)Asia-Pacific Programme for Senior National Security Officers (APPSNO)International Conference on Cohesive Societies (ICCS)International Strategy Forum-Asia (ISF-Asia)
  • Publications
      RSIS PublicationsAnnual ReviewsBooksBulletins and NewslettersRSIS Commentary SeriesCounter Terrorist Trends and AnalysesCommemorative / Event ReportsFuture IssuesIDSS PapersInterreligious RelationsMonographsNTS InsightPolicy ReportsWorking Papers
      External PublicationsAuthored BooksJournal ArticlesEdited BooksChapters in Edited BooksPolicy ReportsWorking PapersOp-Eds
      Glossary of AbbreviationsPolicy-relevant Articles Given RSIS AwardRSIS Publications for the YearExternal Publications for the Year
  • Media
      News ReleasesSpeechesVideo/Audio Channel
  • Events
  • Contact Us
    • Getting to RSIS

      Nanyang Technological University
      Block S4, Level B3,
      50 Nanyang Avenue,
      Singapore 639798

      Click here for direction to RSIS

      Connect with Us

      rsis.ntu
      rsis_ntu
      rsisntu
      rsisvideocast
      school/rsis-ntu
      rsis.sg
      rsissg
      RSIS
      RSS
      Subscribe to RSIS Publications
      Subscribe to RSIS Events
Connect
Search
  • RSIS
  • Publication
  • RSIS Publications
  • The US Case: What Can We Learn From It?
  • Annual Reviews
  • Books
  • Bulletins and Newsletters
  • RSIS Commentary Series
  • Counter Terrorist Trends and Analyses
  • Commemorative / Event Reports
  • Future Issues
  • IDSS Papers
  • Interreligious Relations
  • Monographs
  • NTS Insight
  • Policy Reports
  • Working Papers

CO21139 | The US Case: What Can We Learn From It?
Cung Vu

15 September 2021

download pdf

SYNOPSIS

For almost two years, more than 200 million people worldwide have been infected with COVID-19 resulting in more than 4.5 million deaths. The US has been playing a critical role in addressing the pandemic. What could one learn from its successes and challenges?


Source: Pixabay

COMMENTARY

WHILE DEVELOPED countries are trying to re-open borders to resume global activities, developing countries are still struggling to control their fatality rates due to unavailability of vaccines. What are the successes and challenges one could learn from the United States, where more than 40 million people have been infected so far, with more than 650,000 deaths?

Successes

Vaccine development: The US vaccines approved to date either as fully authorised or for emergency use only are Pfizer-BioNTech, Moderna and Johnson & Johnson. Both Pfizer and Moderna vaccines are based on m-RNA which teaches the immune system to prevent infection from the COVID-19. The Johnson & Johnson vaccine teaches the immune system to attack the protein that causes the COVID-19 to infect other cells.

Normally, vaccine development takes a long time — about 10-15 years. Pfizer and Moderna were able to use old technology for new applications, by leveraging on the m-RNA research taken a few decades ago to develop the COVID-19 vaccine.

Government support: At the onset of the pandemic, the Trump administration was able to speed up the logistics to design, build and distribute ventilators and personal protection equipment to reduce the death rate of COVID-19 patients. It also pumped in money to invest and/or to order in advance a number of vaccines being developed such that if and when it worked, vaccines could be produced in a short time and in large quantities for the US.

As Pfizer and Moderna vaccines were approved for emergency use only in January 2021, the Biden administration was successful in delivering the vaccines to the people. This requires coordinated efforts from the federal government and states to the local authorities to work out the most practical ways to vaccinate people from mass vaccination sites, hospitals, pharmacies and so on.

It was so successful such that by the beginning of summer 2021 the US had one of the highest vaccination rates worldwide only behind Israel and the United Kingdom.

Challenges

Follow the science or not: COVID-19 vaccines protect people from getting infected, severely ill, and significantly reduce the death rate. However, since vaccines are not 100% effective at preventing infection, fully vaccinated people could still get COVID-19, but are less likely to develop serious illness than those who are unvaccinated.

Even with the abundance of vaccines in the US, unfortunately, as of now only 176 million people or 53.6% of the population is fully vaccinated. It means approximately 90 million are eligible but decided not to. This provides a breeding ground for the virus to potentially mutate to become new variants. The new variant could be benign or become more contagious and virulent.

The infection and death rates have been increasing since the middle of June 2021. This creates problems for patients who need hospitalisation especially the Intensive Care Unit (ICU). In some states, most of the ICU beds are occupied by the unvaccinated COVID-19 patients thus denying those with other critical diseases.

Freedom and individualism: Whether people agree that public safety should have a higher priority than individual rights or not, in the US, individual freedom has always been one of the country’s key foundations. It allows activities that people in other countries find hard to understand. For instance in Texas one can carry a handgun without a permit or in New Hampshire one can ride a motorcycle without a helmet where the state official motto is “Live Free or Die”.

Because of this culture of freedom, it is very difficult if not possible to mandate, enforce vaccination or mask wearing in public. The legal system is complex where the local authority can challenge the state and the state can challenge the federal government.

Misinformation: This is a very serious problem in the US as it creates mistrust. It is very difficult to control misinformation, especially from politicians, public figures, media networks, who are out to serve their own interests. There is a lot of totally incorrect information about the disease prevention and treatment of COVID-19, therefore reducing the effectiveness of the pandemic management.

Politics: It is undeniable that US politics play a very critical part in addressing the COVID-19 pandemic, with voters deeply polarised. The Democratic Party followers tend to favour mask wearing and vaccination; the Republican Party followers tend to play down the seriousness of the COVID-19.

Incentives: Even with monetary rewards and other incentives, the vaccination rate only achieved a moderate success since those they try to persuade have already been vaccinated.

Learning to Live with COVID-19

Since no single country can solve the pandemic, the Biden administration has restored the US’ relationship with the World Health Organisation (WHO) so as to coordinate a global response to the pandemic. It also contributed US$4 billion to COVAX, the vaccine alliance whose mission is to distribute COVID-19 vaccines to low- and middle-income countries.

By August 2021 the US has shipped 110 million COVID-19 vaccine doses to 65 countries with no strings attached. The US has expanded the number of Centres for Disease Control and Prevention (CDC)’s regional offices to gain first-hand knowledge, including an office in Hanoi in August 2021 to cover Southeast Asia.

The Biden administration is pushing for future preparedness in dealing with potential pandemic with a $65 billion proposal in September 2021 to accelerate vaccine development, testing, production, and early warning systems.

What Next: Lessons to Be Learned

In monitoring what happens in the US, one could draw some lessons:

• old technology could have new applications;
• vaccine distribution is a hands-on operation that involves all parties;
• misinformation creates mistrust which must be controlled to have an effective pandemic management;
• trust is very critical and that is the main reason why the US has so many unvaccinated people;
• achieving global vaccination as quickly as possible is important since the more contagious variant could originate from anywhere such as the Delta variant from India and the Gamma variant from Brazil;
• early warning is critical to minimise the virus spreading early.

The flu virus keeps on mutating and it seems that people now have accepted it as a fact of life to have a flu shot annually. The WHO estimates that annually one billion people worldwide get the flu and 290,000 to 650,000 die.

Almost certainly, the COVID-19 will not go away. What are the number of deaths from COVID-19 that people can accept in order to carry on with normal life? Nobody knows and it depends on the risk level that people are willing to accept. The threshold varies from country to country where it is influenced by factors such as ethnicity, culture, politics, religion, and background.

About the Author

Cung Vu is a Visiting Senior Fellow of the S. Rajaratnam School of International Studies (RSIS), Nanyang Technological University (NTU), Singapore. He was an Associate Director of the Office of Naval Research Global and Chief Science and Technology Adviser of the National Maritime Intelligence-Integration Office, US Department of the Navy. This is part of a series.

Categories: RSIS Commentary Series / Country and Region Studies / Non-Traditional Security / East Asia and Asia Pacific / South Asia / Southeast Asia and ASEAN / Global
comments powered by Disqus

SYNOPSIS

For almost two years, more than 200 million people worldwide have been infected with COVID-19 resulting in more than 4.5 million deaths. The US has been playing a critical role in addressing the pandemic. What could one learn from its successes and challenges?


Source: Pixabay

COMMENTARY

WHILE DEVELOPED countries are trying to re-open borders to resume global activities, developing countries are still struggling to control their fatality rates due to unavailability of vaccines. What are the successes and challenges one could learn from the United States, where more than 40 million people have been infected so far, with more than 650,000 deaths?

Successes

Vaccine development: The US vaccines approved to date either as fully authorised or for emergency use only are Pfizer-BioNTech, Moderna and Johnson & Johnson. Both Pfizer and Moderna vaccines are based on m-RNA which teaches the immune system to prevent infection from the COVID-19. The Johnson & Johnson vaccine teaches the immune system to attack the protein that causes the COVID-19 to infect other cells.

Normally, vaccine development takes a long time — about 10-15 years. Pfizer and Moderna were able to use old technology for new applications, by leveraging on the m-RNA research taken a few decades ago to develop the COVID-19 vaccine.

Government support: At the onset of the pandemic, the Trump administration was able to speed up the logistics to design, build and distribute ventilators and personal protection equipment to reduce the death rate of COVID-19 patients. It also pumped in money to invest and/or to order in advance a number of vaccines being developed such that if and when it worked, vaccines could be produced in a short time and in large quantities for the US.

As Pfizer and Moderna vaccines were approved for emergency use only in January 2021, the Biden administration was successful in delivering the vaccines to the people. This requires coordinated efforts from the federal government and states to the local authorities to work out the most practical ways to vaccinate people from mass vaccination sites, hospitals, pharmacies and so on.

It was so successful such that by the beginning of summer 2021 the US had one of the highest vaccination rates worldwide only behind Israel and the United Kingdom.

Challenges

Follow the science or not: COVID-19 vaccines protect people from getting infected, severely ill, and significantly reduce the death rate. However, since vaccines are not 100% effective at preventing infection, fully vaccinated people could still get COVID-19, but are less likely to develop serious illness than those who are unvaccinated.

Even with the abundance of vaccines in the US, unfortunately, as of now only 176 million people or 53.6% of the population is fully vaccinated. It means approximately 90 million are eligible but decided not to. This provides a breeding ground for the virus to potentially mutate to become new variants. The new variant could be benign or become more contagious and virulent.

The infection and death rates have been increasing since the middle of June 2021. This creates problems for patients who need hospitalisation especially the Intensive Care Unit (ICU). In some states, most of the ICU beds are occupied by the unvaccinated COVID-19 patients thus denying those with other critical diseases.

Freedom and individualism: Whether people agree that public safety should have a higher priority than individual rights or not, in the US, individual freedom has always been one of the country’s key foundations. It allows activities that people in other countries find hard to understand. For instance in Texas one can carry a handgun without a permit or in New Hampshire one can ride a motorcycle without a helmet where the state official motto is “Live Free or Die”.

Because of this culture of freedom, it is very difficult if not possible to mandate, enforce vaccination or mask wearing in public. The legal system is complex where the local authority can challenge the state and the state can challenge the federal government.

Misinformation: This is a very serious problem in the US as it creates mistrust. It is very difficult to control misinformation, especially from politicians, public figures, media networks, who are out to serve their own interests. There is a lot of totally incorrect information about the disease prevention and treatment of COVID-19, therefore reducing the effectiveness of the pandemic management.

Politics: It is undeniable that US politics play a very critical part in addressing the COVID-19 pandemic, with voters deeply polarised. The Democratic Party followers tend to favour mask wearing and vaccination; the Republican Party followers tend to play down the seriousness of the COVID-19.

Incentives: Even with monetary rewards and other incentives, the vaccination rate only achieved a moderate success since those they try to persuade have already been vaccinated.

Learning to Live with COVID-19

Since no single country can solve the pandemic, the Biden administration has restored the US’ relationship with the World Health Organisation (WHO) so as to coordinate a global response to the pandemic. It also contributed US$4 billion to COVAX, the vaccine alliance whose mission is to distribute COVID-19 vaccines to low- and middle-income countries.

By August 2021 the US has shipped 110 million COVID-19 vaccine doses to 65 countries with no strings attached. The US has expanded the number of Centres for Disease Control and Prevention (CDC)’s regional offices to gain first-hand knowledge, including an office in Hanoi in August 2021 to cover Southeast Asia.

The Biden administration is pushing for future preparedness in dealing with potential pandemic with a $65 billion proposal in September 2021 to accelerate vaccine development, testing, production, and early warning systems.

What Next: Lessons to Be Learned

In monitoring what happens in the US, one could draw some lessons:

• old technology could have new applications;
• vaccine distribution is a hands-on operation that involves all parties;
• misinformation creates mistrust which must be controlled to have an effective pandemic management;
• trust is very critical and that is the main reason why the US has so many unvaccinated people;
• achieving global vaccination as quickly as possible is important since the more contagious variant could originate from anywhere such as the Delta variant from India and the Gamma variant from Brazil;
• early warning is critical to minimise the virus spreading early.

The flu virus keeps on mutating and it seems that people now have accepted it as a fact of life to have a flu shot annually. The WHO estimates that annually one billion people worldwide get the flu and 290,000 to 650,000 die.

Almost certainly, the COVID-19 will not go away. What are the number of deaths from COVID-19 that people can accept in order to carry on with normal life? Nobody knows and it depends on the risk level that people are willing to accept. The threshold varies from country to country where it is influenced by factors such as ethnicity, culture, politics, religion, and background.

About the Author

Cung Vu is a Visiting Senior Fellow of the S. Rajaratnam School of International Studies (RSIS), Nanyang Technological University (NTU), Singapore. He was an Associate Director of the Office of Naval Research Global and Chief Science and Technology Adviser of the National Maritime Intelligence-Integration Office, US Department of the Navy. This is part of a series.

Categories: RSIS Commentary Series / Country and Region Studies / Non-Traditional Security

Popular Links

About RSISResearch ProgrammesGraduate EducationPublicationsEventsAdmissionsCareersVideo/Audio ChannelRSIS Intranet

Connect with Us

rsis.ntu
rsis_ntu
rsisntu
rsisvideocast
school/rsis-ntu
rsis.sg
rsissg
RSIS
RSS
Subscribe to RSIS Publications
Subscribe to RSIS Events

Getting to RSIS

Nanyang Technological University
Block S4, Level B3,
50 Nanyang Avenue,
Singapore 639798

Click here for direction to RSIS

Get in Touch

    Copyright © S. Rajaratnam School of International Studies. All rights reserved.
    Privacy Statement / Terms of Use
    Help us improve

      Rate your experience with this website
      123456
      Not satisfiedVery satisfied
      What did you like?
      0/255 characters
      What can be improved?
      0/255 characters
      Your email
      Please enter a valid email.
      Thank you for your feedback.
      This site uses cookies to offer you a better browsing experience. By continuing, you are agreeing to the use of cookies on your device as described in our privacy policy. Learn more
      OK
      Latest Book
      more info